HCPCS Code C9095

Inj, tebentafusp-tebn, 1 mcg
Code effective Oct 01, 2022

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9095 is a valid 2026 HCPCS code meaning Inj, tebentafusp-tebn, 1 mcg or (Inj, tebentafusp-tebn, 1 mcg) for short. HCPCS C9095 has been effective since 10/01/2022 and applies to Medical care.


HCPCS Code Details - C9095

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9095
Description

Long description:
Inj, tebentafusp-tebn, 1 mcg

Short description:
Inj, tebentafusp-tebn, 1 mcg

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Oct 01, 2022
Date added Added Jul 01, 2022
Termination date Sep 30, 2022

See also

  • HCPCS C9094 · Inj, sutimlimab-jome, 10 mg

  • HCPCS C9096 · Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.